The alliance of sphingosine-1-phosphate and its receptors in immunity
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Sphingosine-1-phosphate (S1P) is a biologically active metabolite of plasma-membrane sphingolipids that is essential for immune-cell trafficking. Its concentration is increased in many inflammatory conditions, such as asthma and autoimmunity. Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5). Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multiple biological activities of S1P are mediated by five distinct G protein-coupled receptors (S1PR1–5), which are differently expressed in various tissues163.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [163]
In the citing paper
“Sphingosine receptors play an important role in innate immune responses (120), and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [120]
Citations
Cites
1 retracted
Melendez, A. J., & Khaw, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110944200 · Cited by 159
RetractedPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“Two sphingosine kinases ( SPHK1 and SPHK2 ) then phosphorylate sphingosine to generate the lysosphingolipid sphingosine-1-phosphate (S1P”
BackgroundLymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504 · cited 1×
“A breakthrough in the understanding of its mechanism, together with a link to S1PR signalling, came with the realization that FTY720 is a sphingosine analogue that could be phosphorylated by SPHKs to produce a S1PR ligan”
BackgroundCD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149 · cited 1×
“Further support is provided by the well-documented role of S1PR1 in regulating endothelial-cell organization during developmen”
BackgroundSelf-citationOral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054 · cited 1×
“By contrast, treatment of patients with relapsing–remitting multiple sclerosis with considerably lower doses of FTY720 alone has proven to be beneficia”
ResultPromotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787 · cited 1×
“Notable exceptions are the blood, where S1P levels are in the low-micromolar range and are mainly contributed by erythrocytes, and the lymph, where S1P levels are in the hundred-nanomolar rang”
BackgroundEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742 · cited 1×
“More specifically, deletion of the genes that encode both kinases is embryonic lethal and results in embryos lacking S1”
BackgroundSelf-citation
Cited by
Items 201–300 of 634
Sphingosine 1-phosphate, a key mediator of the cytokine network: Juxtacrine signaling
Xia, P., & Wadham, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.004 · Cited by 51
“Several excellent reviews have recently summarised the evidence for the role of S1P in the immune system [4,5].”
BackgroundInfluentialGhasemi, R., Dargahi, L., & Ahmadiani, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.006 · Cited by 50
Montecucco, F., Favari, E., Norata, G. D., Ronda, N., Nofer, J., & Vuilleumier, N. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_14 · Cited by 48
“As S1P levels are increased in many inflammatory conditions, such as in asthma and autoimmunity, the exact mechanism by which S1PR agonists could modulate its function is debated (Rivera et al. 2008).”
BackgroundAlzheimer's disease vaccine development: A new strategy focusing on immune modulation
Marciani, D. J. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.08.008 · Cited by 50
Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues
Borowsky, A. D., Bandhuvula, P., Kumar, A., Yoshinaga, Y., Nefedov, M. D., Fong, L. G., Zhang, M., Baridon, B., Dillard, L. M., de Jong, P. J., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m028084 · Cited by 47
Regulation of blood and vascular cell function by bioactive lysophospholipids
Morris, A. J., Panchatcharam, M., Cheng, H., Federico, L., Fulkerson, Z., Selim, S., Miriyala, S., Escalante‐Alcalde, D., & Smyth, S. S. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03405.x · Cited by 46
Cheng, Q., Ma, S., Lin, D., Mei, Y., Gong, H., Lei, L., Chen, Y., Zhao, Y., Hu, B., Wu, Y., et al. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.59 · Cited by 45
Dynamin 2–dependent endocytosis is required for sustained S1PR1 signaling
Willinger, T., Ferguson, S. M., Pereira, J. P., Camilli, P. V. D., & Flavell, R. A. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131343 · Cited by 51
Symbiont-derived sphingolipids modulate mucosal homeostasis and B cells in teleost fish
Sepahi, A., Cordero, H., Goldfine, H., Esteban, M. Á., & Salinas, I. (2016) · Scientific Reports · doi:10.1038/srep39054 · Cited by 57
Sphingolipids in food and their critical roles in human health
Wang, X., Wang, Y., Xu, J., & Xue, C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1736510 · Cited by 46
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis
Ronca, V., Mancuso, C., Milani, C., Carbone, M., Oo, Y. H., & Invernizzi, P. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0320-200r · Cited by 46
Neuroprotective Therapies for Spontaneous Intracerebral Hemorrhage
Kearns, K. N., Ironside, N. T., Park, M. S., Worrall, B. B., Southerland, A. M., Chen, C., & Ding, D. (2021) · Neurocritical Care · doi:10.1007/s12028-021-01311-3 · Cited by 47
The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages
Ley, S., Weigert, A., Weichand, B., Henke, N., Mille-Baker, B., Janssen, R. A. J., & Brüne, B. (2012) · Oncogene · doi:10.1038/onc.2012.77 · Cited by 54
Verzijl, D., Peters, S. L. M., & Alewijnse, A. E. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0041-z · Cited by 45
“The bioactive sphingolipid S1P regulates a wide variety of physiological processes in the cardiovascular (Peters and Alewijnse, 2007; Takuwa et al., 2008) and immune system ( Rivera et al., 2008 ).”
BackgroundThe safety of non-biological treatments in Ulcerative Colitis
Troncone, E., & Monteleone, G. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1340936 · Cited by 46
S1P-S1PR1 Signaling: the “Sphinx” in Osteoimmunology
Xiao, L., Zhou, Y., Friis, T., Beagley, K. W., & Xiao, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01409 · Cited by 52
“Roles of S1P-S1PR1 in Osteoimmunology When S1P binds with S1PR1, it forms a complex that governs a diverse range of immune cell activities, such as cell migration, proliferation, and differentiation (185).”
BackgroundHuman T lymphocytes at tumor sites
Notarbartolo, S., & Abrignani, S. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00970-4 · Cited by 55
“CD69 post-transcriptionally antagonizes the sphingosine-1-phosphate receptor (S1PR1) [68], which regulates chemotaxis toward the sphingosine-1-phosphate (S1P) produced by the endothelial cells of lymph and blood vessels [69].”
BackgroundBerce, V., Kozmus, C. P., & Potočnik, U. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.36 · Cited by 47
Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells
Fuerst, E., Foster, H. R., Ward, J. P. T., Corrigan, C. J., Cousins, D. J., & Woszczek, G. (2014) · Allergy · doi:10.1111/all.12489 · Cited by 46
“S1P plays an important role in lymphocyte migration (7), but accumulating evidence implicates the involvement of S1P in profibrotic and pro-remodelling responses in the lungs.”
BackgroundDillmann, C., Ringel, C., Ringleb, J., Mora, J., Olesch, C., Fink, A. F., Roberts, E., Brüne, B., & Weigert, A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1403168 · Cited by 45
Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease
Wollny, T., Wątek, M., Durnaś, B., Niemirowicz, K., Piktel, E., Żendzian‐Piotrowska, M., Góźdź, S. S., & Bucki, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040741 · Cited by 47
“S1P released from platelets and mast cells promotes wound healing, participates in the inflammatory response [52], liver fibrosis [53], and has different functions in angiogenesis, and innate and adaptive immunity [24].”
BackgroundBadawy, S. M. M., Okada, T., Kajimoto, T., Hirase, M., Matovelo, S. A., Nakamura, S., Yoshida, D., Ijuin, T., & Nakamura, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001986 · Cited by 48
“Sphingosine 1-phosphate (S1P), a phosphorylated product of sphingosine catalyzed by sphingosine kinase (SphK), has emerged as a potent lipid mediator with diverse effects on multiple biological processes including angiogenesis (21), cardiac development (22), immunity (23), neurotransmitter release (24) and maturation…”
BackgroundLiver acid sphingomyelinase inhibits growth of metastatic colon cancer
Osawa, Y., Suetsugu, A., Matsushima‐Nishiwaki, R., Yasuda, I., Saibara, T., Moriwaki, H., Seishima, M., & Kozawa, O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65188 · Cited by 47
“S1P is a ceramide-derived metabolite that is involved in various cellular functions and increases migration of macrophages (16, 17), resulting in macrophage recruitment.”
FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus
Shi, D., Tian, T., Yao, S., Cao, K., Zhu, X., Zhang, M., Wen, S., Li, L., Shi, M., & Zhou, H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.009 · Cited by 48
Kurashima, Y., & Kiyono, H. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.7 · Cited by 50
Post-translational regulation of sphingosine kinases
Chan, H., & Pitson, S. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.005 · Cited by 50
Lucaciu, A., Kuhn, H., Trautmann, S., Ferreirós, N., Steinmetz, H., Pfeilschifter, J. M., Brunkhorst, R., Pfeilschifter, W., Subburayalu, J., & Vutukuri, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176242 · Cited by 44
“How these cells respond chemotactically to S1P may be subject to their unique S1PR repertoire [39,58], which we found to be differentially patterned after MCAO.”
BackgroundSun, X., Ma, S., Wade, M. S., Flores, C., Pino-Yanes, M. D. M., Moitra, J., Ober, C., Kittles, R. A., Husain, A. N., Ford, J. G., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.036 · Cited by 47
Interface between hemostasis and adaptive immunity
Qu, Z., & Chaikof, E. L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.08.017 · Cited by 43
Effects of Lysophospholipids on Tumor Microenvironment
Rolin, J., & Maghazachi, A. A. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0088-1 · Cited by 42
“It is generated from sphingolipids, which are essential plasma membrane lipids concentrated in liquid-ordered domains, commonly known as lipid rafts [21].”
BackgroundSpace radiation-associated lung injury in a murine model
Christofidou-Solomidou, M., Pietrofesa, R. A., Arguiri, E., Schweitzer, K. S., Berdyshev, E. V., McCarthy, M., Corbitt, A., Alwood, J. S., Yu, Y., Globus, R. K., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00260.2014 · Cited by 41
Suh, J. H., Degagné, É., Gleghorn, E. E., Setty, M., Rodriguez, A., Park, K. T., Verstraete, S. G., Heyman, M. B., Patel, A., Irek, M., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy007 · Cited by 41
The Lipid Status in Patients with Ulcerative Colitis: Sphingolipids are Disease-Dependent Regulated
Bazarganipour, S., Hausmann, J., Oertel, S., El-Hindi, K., Brachtendorf, S., Blumenstein, I., Kubesch, A., Sprinzl, K., Birod, K., Hahnefeld, L., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070971 · Cited by 45
“S1P belongs to the group of sphingolipids which play a distinct role as a second messenger in signaling pathways and are essential for physiological properties of cell membranes [14,15].”
Backgrounddas Neves, M. F., Batuca, J. R., & Alves, J. D. (2021) · Immunology · doi:10.1111/imm.13348 · Cited by 42
“[20] S1P binds to cells through its own cell surface receptors, contributing to immune cell trafficking and endothelial barrier function.[21] ApoM, a negative acute- phase protein, is the carrier of S1P in HDL.”
BackgroundS1P/S1PR signaling pathway advancements in autoimmune diseases
Li, J., Huang, Y., Zhang, Y., Liu, P., Liu, M., Zhang, M., & Wu, R. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9082 · Cited by 45
“Erythrocytes, platelets, and endothelial cells are the primary sources of circulating S1P ([9]), although mast cells and platelets can also produce excessive amounts of S1P in an inflammatory or pre-thrombotic state ([10]).”
BackgroundMolecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis
Nicoletti, F., di Nuzzo, L., Orlando, R., & Nasca, C. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s52428 · Cited by 43
“S1P is present in relatively high concentrations in the blood and lymph, but in lower concentrations inside the lymph nodes and other organs.(8) The concentration gradient between circulatory fluids and tissue interstitium is critical for the regulation of cell migration by S1P.”
Dave, J. M., Kang, H., Abbey, C. A., Maxwell, S. A., & Bayless, K. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512467 · Cited by 40
Current and Emerging Systemic Treatment Strategies for Psoriasis
Laws, P., & Young, H. S. (2012) · Drugs · doi:10.2165/11634980-000000000-00000 · Cited by 46
“Migration from the peripheral tissue to the regional lymph node is driven and regulated in part by sphingosine 1-phosphate (S1P) receptor agonists.([107]) ACT-12880 is an S1P1 agonist and is undergoing phase II clinical trials for psoriasis.”
Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis
Rolin, J., & Maghazachi, A. A. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.1113571 · Cited by 45
Muñoz-Cano, R., Pascal, M., Bartra, J., Picado, C., Valero, A., Kim, D.-K., Brooks, S., Ombrello, M., Metcalfe, D. D., Rivera, J., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.042 · Cited by 40
Self-citationSphingosine 1-Phosphate Signaling at the Skin Barrier Interface
Masuda‐Kuroki, K., & Nardo, A. D. (2022) · Biology · doi:10.3390/biology11060809 · Cited by 48
“Sphingosine can be phosphorylated by sphingosine kinases (SphK1 and SphK2), leading to the formation of S1P [2,3,15].”
BackgroundHamidi, S., Schäfer‐Korting, M., & Weindl, G. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.01.008 · Cited by 44
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis
Giannone, F., Malpeli, G., Lisi, V., Grasso, S., Shukla, P., Ramarli, D., Sartoris, S., Monsurrò, V., Krampera, M., Amato, E., et al. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0134 · Cited by 42
“The lymphoid tissue-specific S1PR4 is part of a family of receptors responding to lysophospholipids or lysosphingolipids (Rivera et al. 2008).”
BackgroundPlasma Sphingosine 1-Phosphate Levels and the Risk of Vertebral Fracture in Postmenopausal Women
Kim, B., Koh, J., Lee, S., Lee, Y., Lee, S. H., Lim, K.-H., Cho, E.-H., Kim, S., Kim, T., Kim, S., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2346 · Cited by 40
“ulating the homeostatic levels of S1P in the blood (31).”
BackgroundMa, Y., Liu, G., Tang, M., Fang, J. Q., & Jiang, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640305 · Cited by 47
“Sphingolipids are an essential part of the structure of biological membranes, and an increasing number of studies have shown that they are closely related to immunity and inhibiting inflammation (45, 46).”
BackgroundFTY720 Regulates Bone Marrow Egress of Eosinophils and Modulates Late-Phase Skin Reaction in Mice
Sugita, K., Kabashima, K., Sakabe, J., Yoshiki, R., Tanizaki, H., & TOKURA, Y. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100119 · Cited by 41
How do sphingosine-1-phosphate affect immune cells to resolve inflammation?
Sun, G., Wang, B., Wu, X., Cheng, J., Ye, J., Wang, C., Zhu, H., & Liu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362459 · Cited by 57
“Both S1PR1-S1PR5 are involved in regulating APC function and metabolism (114, 115).”
BackgroundJujić, A., Matthes, F., Vanherle, L., Petzka, H., Orho‐Melander, M., Nilsson, P. M., Magnusson, M., & Meißner, A. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.17379 · Cited by 39
SnapShot: Bioactive Lysophospholipids
Moolenaar, W. H., & Hla, T. (2012) · Cell · doi:10.1016/j.cell.2012.01.013 · Cited by 39
Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy
González‐Fernández, B., Sánchez, D. I., González‐Gallego, J., & Tuñón, M. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00579 · Cited by 38
“SphKs are activated by numerous stimuli, including proinflammatory cytokines, chemokines and intercellular adhesion molecules (Rivera et al., 2008).”
BackgroundChiricozzi, E., Loberto, N., Schiumarini, D., Samarani, M., Mancini, G., Tamanini, A., Lippi, G., Dechecchi, M. C., Bassi, R., Giussani, P., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0717-269r · Cited by 40
Li, Y.-J., Shi, S. X.-Y., Liu, Q., Shi, F., & Gonzales, R. J. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135160 · Cited by 37
Haberberger, R. V., Tabeling, C., Runciman, S., Gutbier, B., König, P., Andratsch, M., Schütte, H., Suttorp, N., Gibbins, I. L., & Witzenrath, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.034 · Cited by 38
Arlt, O., Schwiebs, A., Japtok, L., Rüger, K., Katzy, E., Kleuser, B., & Radeke, H. H. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362982 · Cited by 41
Raine, T., Liu, J. Z., Anderson, C. A., Parkes, M., & Kaser, A. (2014) · Gut · doi:10.1136/gutjnl-2013-306657 · Cited by 40
Igawa, S., Choi, J. E., Wang, Z., Chang, Y.-L., Wu, C., Werbel, T., Ishida‐Yamamoto, A., & Nardo, A. D. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.02.010 · Cited by 38
Jeon, S., Song, J., Lee, D., Kim, G., Park, S., Shin, D., Shin, K., Park, K., Shim, S., & Park, T. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000254 · Cited by 37
“siderably elevated S1P levels in circulation and liver (21, 32) as well as in the immune system (1, 22).”
BackgroundNotch signaling licenses allergic airway inflammation by promoting Th2 cell lymph node egress
Tindemans, I., van Schoonhoven, A., KleinJan, A., de Bruijn, M. J. W., Lukkes, M. M., van Nimwegen, M., van den Branden, A., Bergen, I. M., Corneth, O. B. J., van IJcken, W. F. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128310 · Cited by 37
“Transmigration of S1PR1expressing T cells into lymphatic sinuses and subsequent egress into efferent lymph are mediated by an S1P gradient across lymphoid endothelial cells (LECs) (52).”
BackgroundmiR-155 indicates the fate of CD4+ T cells
Chen, L., Gao, D., Shao, Z., Zheng, Q., & Yu, Q. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.05.003 · Cited by 40
Ratajczak, M. Z., Kim, C., Janowska‐Wieczorek, A., & Ratajczak, J. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/758512 · Cited by 43
Cho, H., & Kehrl, J. H. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)86009-2 · Cited by 38
Barth, B. M., Shanmugavelandy, S. S., Kaiser, J. M., McGovern, C. O., Altınoğlu, E. İ., Haakenson, J. K., Hengst, J. A., Gilius, E. L., Knupp, S. A., Fox, T. E., et al. (2013) · ACS Nano · doi:10.1021/nn304862b · Cited by 37
Fingolimod and cardiac risk: latest findings and clinical implications
Vargas, W. S., & Perumal, J. S. (2013) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098613481023 · Cited by 35
Sphingosine 1-phosphate lyase enzyme assay using a BODIPY-labeled substrate
Bandhuvula, P., Li, Z., Bittman, R., & Saba, J. D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.106 · Cited by 34
“S1P signals through a family of five known G protein-coupled membrane receptors that regulate cell survival, migration, and complex processes such as vascular maturation and lymphocyte trafficking [3–5].”
BackgroundRahmatpanah, F. B., Agrawal, S., Scarfone, V. M., Kapadia, S., Mercola, D., & Agrawal, A. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly106 · Cited by 44
“SIPR4 is expressed on DCs from mouse lungs while SIPR1 and SIPR3 expression is increased on DC maturation which facilitates DC migration (50).”
BackgroundRole of Bioactive Sphingolipids in Inflammation and Eye Diseases
Mondal, K., & Mandal, N. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_14 · Cited by 35
Immunological Function of Sphingosine 1-Phosphate in the Intestine
Kunisawa, J., & Kiyono, H. (2012) · Nutrients · doi:10.3390/nu4030154 · Cited by 34
“Among various lipid mediators, sphingosine-1-phosphate (S1P) is a biologically active sphingolipid that regulates cell trafficking and activation [4,5].”
BackgroundInfluentialSphingolipid Pathway Enzymes Modulate Cell Fate and Immune Responses
Molino, S., Tate, E. R., McKillop, W. M., & Medin, J. A. (2017) · Immunotherapy · doi:10.2217/imt-2017-0089 · Cited by 35
Dong, J., Wang, H., Wu, G.-H., Zhao, J., Zhang, L., Zuo, L., Zhu, W., Gong, J., Li, Y., Gu, L., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12304 · Cited by 35
Podbielska, M., Krotkiewski, H., & Hogan, E. L. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0728-y · Cited by 38
Post-translational modifications of S1PR1 and endothelial barrier regulation
Anwar, M., & Mehta, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158760 · Cited by 39
A novel memory-like Tfh cell subset is precursor to effector Tfh cells in recall immune responses
Han, F., Zhao, Z., Zhao, X., Bai, X., Fu, W., Zheng, L., Kang, B., Wang, X., Zhang, Z., & Dong, C. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221927 · Cited by 35
“In the meantime, cells in C3 specifically upregulated expression of genes related to memory T cell formation, such as Sell , Lef1 , and Ccr7 (Seder and Ahmed, 2003; Sallusto et al., 2004; Mueller et al., 2013; Zhao et al., 2010), as well as genes involved in cellular localization and migration, including S1pr1 , Itgb7…”
BackgroundSphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases
Arish, M., Husein, A., Kashif, M., Saleem, M., Akhter, Y., & Rub, A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.09.013 · Cited by 34
PTEN regulates natural killer cell trafficking in vivo
Leong, J. W., Schneider, S. E., Sullivan, R. P., Parikh, B. A., Anthony, B. A., Singh, A., Jewell, B. A., Schappe, T., Wagner, J. A., Link, D. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413886112 · Cited by 35
“S1P concentrations are highest in the peripheral blood and lymph and are important for NK cell exit to these sites (42).”
BackgroundGarcía‐Bernal, D., Redondo-Muñóz, J., Dios‐Esponera, A., Chèvre, R., Bailón, E., Garayoa, M., Arellano‐Sánchez, N., Gutierrez, N. C., Hidalgo, A., García-Pardo, A., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4066 · Cited by 37
S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling
Kumar, A., Zamora-Pineda, J. B., Degagné, É., & Saba, J. D. (2017) · Mediators of Inflammation · doi:10.1155/2017/7685142 · Cited by 33
“Furthermore, the development and differentiation of leukocytes, mast cell degranulation, and antigen presenting cell functions are also influenced by S1P signaling [30, 31].”
BackgroundIshii, T., Shimazu, Y., Nishiyama, I., Kikuta, J., & Ishii, M. (2011) · Molecules and Cells · doi:10.1007/s10059-011-1010-x · Cited by 32
“S1P signals via five 7-transmembrane receptors or G proteincoupled receptors (GPCRs), S1PR1 to S1PR5, previously referred to as endothelial differentiation gene (Edg) receptors (Rivera et al., 2008; Rosen et al., 2007).”
BackgroundEmerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma
Kumar, A., Nema, R., Vishwakarma, S., Agarwal, R., & Panday, R. K. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s99989 · Cited by 39
“It mediates most of its functions by binding to a family of G-protein-coupled receptors, formerly termed endothelial differentiation genes, but now these receptors are known as S1PRs 1–5.(29,31,32) In addition to mediating effects via extracellular receptormediated signaling, S1P also acts intracellularly and independ…”
Kays, J. S., Li, C., & Nicol, G. D. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00053.2012 · Cited by 32
“An array of immunocompetent cells, such as platelets and mast cells, release S1P upon activation where it may function in an autocrine and/or paracrine signaling capacity (13, 35, 41, 55).”
BackgroundHsu, L.-C., Reddy, S. V., Yilmaz, Ö., & Yu, H. H. (2019) · Cells · doi:10.3390/cells8010017 · Cited by 33
“S1P can be degraded by S1P lyase or dephosphorylated by S1P phosphatase [15,16].”
BackgroundInfluentialZahiri, D., Burow, P., Großmann, C., Müller, C. E., Klapperstück, M., & Markwárdt, F. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118915 · Cited by 31
Lasa, J. S., Olivera, P. A., Bonovas, S., Danese, S., & Peyrin‐Biroulet, L. (2021) · Drug Safety · doi:10.1007/s40264-021-01057-z · Cited by 30
“Sphingosine-1-phosphate 1 regulates the trafficking of lymphocytes out of the secondary lymphoid organs into the blood and lymph [6]; it may also have a role in the development of bradycardia.”
BackgroundThe Role of Sphingolipids in Allergic Disorders
Díaz‐Perales, A., Escribese, M. M., Garrido‐Arandia, M., Obeso, D., Izquierdo, E., Tomé‐Amat, J., & Barber, D. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.675557 · Cited by 33
“In addition, S1P regulates the activation and functions of many immune cells and regulates diverse immunological processes (14, 23, 24).”
BackgroundKarmouty‐Quintana, H., Siddiqui, S., Hassan, M., Tsuchiya, K., Risse, P., Xicota, L., Martí-Solano, M., & Martin, J. G. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00050.2011 · Cited by 32
“In these models, FTY720 is thought to mediate its effects via sequestration of activated T cells away from sites of inflammation (32).”
BackgroundResultInfluentialLow Sphingosine-1–Phosphate Impairs Lung Dendritic Cells in Cystic Fibrosis
Xu, Y., Krause, A., Limberis, M. P., Worgall, T. S., & Worgall, S. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0021oc · Cited by 31
“Critical for these activators are a S1P gradient between blood and tissue compartments and the presence of S1P receptors (21, 22).”
BackgroundTargeting sphingosine-1-phosphate signaling for cancer therapy
Xie, Z., Liu, H., & Geng, M. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9046-6 · Cited by 31
Sphingosine kinase inhibitors: A patent review
Cao, M., Ji, C., Zhou, Y., Huang, W. R. H., Ni, W., Tong, X., & Wei, J. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3505 · Cited by 36
“For example, S1PR1 is decisive for T and B cell egress from lymph nodes and for the exit of mature thymocytes, both conventional T cells and natural killer T (NKT) cells (94).”
Store-operated calcium entry in disease: Beyond STIM/Orai expression levels
Kappel, S., Borgström, A., Stokłosa, P., Dörr, K., & Peinelt, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.01.003 · Cited by 30
Sphingolipids in Atherosclerosis: Chimeras in Structure and Function
Peters, L., Kuebler, W. M., & Simmons, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911948 · Cited by 32
Tian, J., Chang, S., Wang, J., Chen, J., Xu, H., Huang, T., Wang, J., Kang, J., Fan, W., & Wang, Y. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2023.06.006 · Cited by 34
The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease
Fa, P., Ke, B. G., Dupre, A., Tsung, A., & Zhang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1292679 · Cited by 33
Ardawi, M. M., Rouzi, A. A., Al-Senani, N. S., Qari, M. H., Elsamanoudy, A. Z., & Mousa, S. A. (2018) · Journal of Bone Metabolism · doi:10.11005/jbm.2018.25.2.87 · Cited by 30
“However, neither platelets nor mast cells were shown to play a role in controlling S1P homeostasis in the blood.[31] Plasma S1P levels were measured using a commercially well-validated assay method and no significant differences were evident between basal mean plasma S1P levels and S1P levels in those who died during…”
MethodMartín‐Hernández, D., Martínez, M., Robledo‐Montaña, J., Muñoz‐López, M., Virto, L., Ambrosio, N., Marín, M. J., Montero, E., Herrera, D., Sanz, M., et al. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13780 · Cited by 34
The Immune Response to Nematode Infection
Stear, M. J., Preston, S., Piedrafita, D. M., & Donskow‐Łysoniewska, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032283 · Cited by 43
“Sphingosine-1-phosphate is a metabolite of plasma membrane glycolipids that plays an essential role in immune cell trafficking [54], especially in the migration of activated lymphocytes from lymph nodes.”
BackgroundFernández‐Pisonero, I., López, J., Onecha, E., Dueñas, A. I., Maeso, P. A., Crespo, M. S., Román, J. A. S., & García‐Rodríguez, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109081 · Cited by 33
“S1P can either act as an intracellular second messenger or on the cell surface in an autocrine or paracrine manner by binding to G protein-coupled receptors known as S1P1-5, which generate multiple signals and a fine-tuning of specific responses [8], [11].”
BackgroundAcid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment
Yu, F. P. S., Sajdak, B. S., Sikora, J., Salmon, A. E., Nagree, M. S., Gurka, J., Kassem, I. S., Lipinski, D. M., Carroll, J., & Medin, J. A. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.018 · Cited by 29
The Sphingolipid Rheostat: A Potential Target for Improving Pancreatic Islet Survival and Function
Jessup, C. F., Bonder, C. S., Pitson, S. M., & Coates, P. T. (2011) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153011797881201 · Cited by 32
The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined
Jin, L., Liu, W.-R., Tian, M., Fan, J., & Shi, Y. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0884-7 · Cited by 32
“On a macro level, SphKs are activated by numerous stimuli, including chemokines, intercellular adhesion molecules, and pro-inflammatory cytokines [4, 5].”
BackgroundBarnawi, J., Tran, H. B., Roscioli, E., Hodge, G. L., Jersmann, H. P. A., Haberberger, R. V., & Hodge, S. J. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2016.1153614 · Cited by 32
“to contribute to macrophage dysfunction, given their roles in trafficking and migration (81) and our previous findings of an association between S1PR5 and the reduced phagocytic ability”
BackgroundInoue, T., Kohno, M., Nagahara, H., Murakami, K., Sagawa, T., Kasahara, A., Kaneshita, S., Kida, T., Fujioka, K., Wada, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218090 · Cited by 29
Metadata
- Authors
- Rivera, J., Proia, R. L., & Olivera, A.
- Affiliations
- National Institutes of Health (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- Corresponding author
- Rivera, Juan
- Venue
- Nature Reviews Immunology
- Published
- 2008-10
- Volume
- 8
- Issue
- 10
- Pages
- 753-763
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2600775
- OpenAlex
- W1967802627
- Cited by
- 616
- References
- 108
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 30 · 2022: 26 · 2021: 38 · 2020: 30 · 2019: 40 · 2018: 37 · 2017: 34 · 2016: 41 · 2015: 36 · 2014: 46 · 2013: 46 · 2012: 58
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01AR041155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, immune cell trafficking, immunomodulation, immune surveillance, immune cell function, inflammation, asthma, autoimmunity, sphingolipids
- MeSH terms
- Animals, Cell Movement, Chemotaxis, Dendritic Cells, Humans, Lymphocytes, Lysophospholipids, Macrophages, Mast Cells, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.